top of page
Clinical Trial for AI-Enabled Drug
EU AI Act and Its Application in Developing Rare Disease Therapies for Neurological Disorders
The EU AI Act (Artificial Intelligence Act Regulation EU 2024/1689), which came into force on 1 August 2024, establishes a harmonised framework for regulating AI systems. It impacts the use of AI in medical settings, particularly when integrated with the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR).
Camilla Costa
Jul 275 min read
AI in Pharma: Job Killer or Opportunity for Innovation and Growth?
In this article, we will explore how AI is reshaping the pharmaceutical landscape and examine its implications for the workforce, presenting a balanced view on the potential benefits and challenges ahead.
Camilla Costa
Jul 214 min read
Structuring Clinical Trials for AI-Enabled Drug Discovery Platforms: A Comprehensive Guide
In the fast-paced world of drug discovery, artificial intelligence (AI) has become essential, transforming the way researchers identify...
Camilla Costa
May 124 min read
bottom of page